Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

639.95

INR
+23.55(+3.82%)
As of December 27, 2024 9:58:00 AM

Valuation Metrics

Market Cap
₹1894.06 Cr
Enterprise Value
₹1788.14 Cr
P/E Ratio (TTM)
79.54
Forward P/E
NA
PEG Ratio
-4.74
Price to Sales (TTM)
8.35

Financial Metrics

Gross Margin
64.71%
Operating Margin
18.67%
Return on Equity
13.26%
Revenue (TTM)
₹226.85 Cr+29.2%
EBITDA
₹40.66 Cr
EPS (TTM)
₹8.97+53.400000000000006%

Balance Sheet

Total Cash
₹77.84 Cr
Total Debt
₹9.81 Cr
Debt to Equity
4.98%

Stock Information

52 Week Range
₹273.6 - ₹820.1
Beta
1.05
Shares Outstanding
₹2.65 Cr

Dividends & Splits

Forward Dividend Yield
3.13%
Trailing Dividend Yield
NA
Payout Ratio
55.56%

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

639.95

INR
+23.55(+3.82%)
As of December 27, 2024 9:58:00 AM

Valuation Metrics

Market Cap
₹1894.06 Cr
Enterprise Value
₹1788.14 Cr
P/E Ratio (TTM)
79.54
Forward P/E
NA
PEG Ratio
-4.74
Price to Sales (TTM)
8.35

Financial Metrics

Gross Margin
64.71%
Operating Margin
18.67%
Return on Equity
13.26%
Revenue (TTM)
₹226.85 Cr+29.2%
EBITDA
₹40.66 Cr
EPS (TTM)
₹8.97+53.400000000000006%

Balance Sheet

Total Cash
₹77.84 Cr
Total Debt
₹9.81 Cr
Debt to Equity
4.98%

Stock Information

52 Week Range
₹273.6 - ₹820.1
Beta
1.05
Shares Outstanding
₹2.65 Cr

Dividends & Splits

Forward Dividend Yield
3.13%
Trailing Dividend Yield
NA
Payout Ratio
55.56%